Breaking News
Sort by:
Top Post
NuraLogix Researchers Announce AI Models That Can Predict Blood Biomarker Risk
Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed […]
NHS Trials Smart Goggles to Give Nurses More Time With Patients
High tech goggles will be worn by community nurses on home visits to free up […]
DotLab Announces Three Granted Patents for Its Non-invasive Test for Endometriosis, DotEndo™
DotLab, a medical diagnostics company, announced that the United States Patent and Trademark Office has […]
Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on Its Semiconductor Chip
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]
Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the […]
Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseqTM) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Bio-Rad Launches CFX Duet Real-Time PCR System
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
CHOP Researchers Develop New Computational Tool to Interpret Clinical Significance of Cancer Mutations
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret […]
A Non-Invasive Digital Therapeutic, JOGO-Gx, Shows Early Success in Treating Parkinson's Disease Symptoms
JOGO-Gx, a non-invasive digital therapeutic built with AI and wearables that taps into the neuroplasticity […]
Gyros Protein Technologies Introduces PurePep Sonata+ Peptide Synthesizer
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more